1. Home
  2. MRUS vs PAM Comparison

MRUS vs PAM Comparison

Compare MRUS & PAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • PAM
  • Stock Information
  • Founded
  • MRUS 2003
  • PAM 1945
  • Country
  • MRUS Netherlands
  • PAM Argentina
  • Employees
  • MRUS N/A
  • PAM N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • PAM Electric Utilities: Central
  • Sector
  • MRUS Health Care
  • PAM Utilities
  • Exchange
  • MRUS Nasdaq
  • PAM Nasdaq
  • Market Cap
  • MRUS 4.1B
  • PAM 4.4B
  • IPO Year
  • MRUS 2016
  • PAM N/A
  • Fundamental
  • Price
  • MRUS $52.90
  • PAM $68.61
  • Analyst Decision
  • MRUS Strong Buy
  • PAM Buy
  • Analyst Count
  • MRUS 12
  • PAM 3
  • Target Price
  • MRUS $87.92
  • PAM $85.83
  • AVG Volume (30 Days)
  • MRUS 1.2M
  • PAM 157.3K
  • Earning Date
  • MRUS 07-31-2025
  • PAM 08-06-2025
  • Dividend Yield
  • MRUS N/A
  • PAM N/A
  • EPS Growth
  • MRUS N/A
  • PAM 32.60
  • EPS
  • MRUS N/A
  • PAM 0.41
  • Revenue
  • MRUS $54,732,000.00
  • PAM $1,970,436,590.00
  • Revenue This Year
  • MRUS $75.57
  • PAM $23.47
  • Revenue Next Year
  • MRUS $31.84
  • PAM $22.99
  • P/E Ratio
  • MRUS N/A
  • PAM $6.91
  • Revenue Growth
  • MRUS 42.77
  • PAM 21.62
  • 52 Week Low
  • MRUS $33.19
  • PAM $38.58
  • 52 Week High
  • MRUS $62.98
  • PAM $97.55
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 54.86
  • PAM 39.10
  • Support Level
  • MRUS $52.53
  • PAM $69.40
  • Resistance Level
  • MRUS $54.81
  • PAM $73.28
  • Average True Range (ATR)
  • MRUS 1.70
  • PAM 2.41
  • MACD
  • MRUS -0.55
  • PAM -0.47
  • Stochastic Oscillator
  • MRUS 39.04
  • PAM 11.72

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About PAM Pampa Energia S.A.

Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.

Share on Social Networks: